Loew Caroline 4/A
4/A · Mural Oncology plc · Filed Apr 11, 2024
Insider Transaction Report
Form 4/AAmended
Loew Caroline
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-12-14+379,690→ 379,690 totalExercise: $5.48Exp: 2033-07-02→ Ordinary Shares (379,690 underlying)
Footnotes (3)
- [F1]This amendment to Form 4 is being filed solely to correct the exercise price of the granted option, which was previously reported as being $3.61 due to a scrivener's error.
- [F2]Represents an option award originally granted by Alkermes plc ("Alkermes") that was converted into an option award of Mural Oncology plc (the "Issuer") in connection with the spin-off of the Issuer from Alkermes.
- [F3]This option was granted on December 14, 2023. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of July 5, 2023, subject to the reporting person's continued service with the Issuer.